Tag: diabetes mellitus type ii

‘Shocking’ Early Complications From Teen-Onset Type 2 Diabetes

Newly published data show alarmingly high rates and severity of early diabetes-specific complications in individuals who develop type 2 diabetes at a young age. This...

HF Med Cornucopia Center Stage in Upcoming ESC Guideline: Preview

Today there are so many evidence-based drug therapies for heart failure (HF) with reduced ejection fraction (HFrEF) that physicians treating HF patients almost don’t know...

Cognitive Deficits Linked to CV Risk Factors in Diabetes

In type 2 diabetes (T2D), a greater degree of hyperlipidemia and hypertension, although not hyperglycemia, was associated with measurable cognitive impairment even among patients with...

FDA OKs Extended-Release Exenatide for Children With T2D

The Food and Drug Administration has approved exenatide extended release (Bydureon/Bydureon BCise, AstraZeneca) for use in children with type 2 diabetes down to 10 years...

Medicare Struggles to Expand Diabetes Prevention Program

Damon Diessner tried for years to slim down from his weight of more than 400 pounds, partly because his size embarrassed his wife but even...

Necessary or Not, COVID Booster Shots Are Probably on the Horizon

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The drugmaker Pfizer recently announced that vaccinated people are likely to...

FDA Approves Finerenone for Slowing CKD in Type 2 Diabetes

The US Food and Drug Administration (FDA) approved finerenone (Kerendia), the first agent from a new class of nonsteroidal mineralocorticoid receptor antagonists (MRAs), on July...

Positive Top-Line Results for Empagliflozin in HFpEF

Treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) significantly reduces the risk of cardiovascular death or hospitalization for heart failure...

Digital Diabetes Coaching Systems: Too Expensive or Worthwhile?

Dr Anne L. Peters Digital coaching systems for type 2 diabetes “reduce the need for more expensive, in-person visits,” said Anne L. Peters, MD, arguing...

Project in Black Churches Improves A1c

Dr Gretchen Piatt A church-based diabetes self-management support intervention that incorporated parish nurses and peer leaders is feasible and may help improve diabetes-related outcomes in...

Heartburn Drugs Improve Blood Sugar Control in Diabetes

WASHINGTON—Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to...

Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes

Heart failure (HF) guidelines and practice have been quick to embrace the sodium-glucose cotransporter 2 (SGLT2) inhibitor drug class after DAPA-HF, EMPEROR-Reduced, and other trials...

Walmart to Sell Cheaper Insulin; Advocates Say It’s Still Expensive

The retail giant Walmart has launched its first private brand of analog insulin in the United States called ReliOn Novolog (insulin aspart). The new product...

Diabetes and Sleep Disturbances Can Be a Lethal Combination

Dr Kristen L. Knutson A single, simple question about sleep habits asked to people with diabetes in the UK Biobank database identified a subgroup with...

‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes

Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2...

More Data Link Unmanaged Diabetes, High Glucose to Severe COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Unmanaged diabetes and high blood glucose levels are linked to more...

‘Staggering’ Doubling of Type 2 Diabetes in Kids During Pandemic

The incidence of type 2 diabetes in children appears to have doubled during the COVID-19 pandemic, data from two new US studies suggest, with the...

A1c Below Prediabetes Cutoff Linked to Subclinical Atherosclerosis

Hemoglobin A1c above 5% but below the prediabetes cutoff of 5.5% is an additional potential biomarker of subclinical atherosclerosis in people with low cardiovascular disease...

FDA Approves ‘Gamechanger’ Semaglutide for Weight Loss

The US Food and Drug Administration (FDA) has approved a 2.4 mg/week subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...

Finerenone Cuts New AF in Type 2 Diabetes and CKD

Finerenone treatment of patients with type 2 diabetes and diabetic kidney disease was linked to a significant drop in the incidence of new-onset atrial fibrillation as...

FDA Blazes Path for ‘Real-World’ Evidence as Proof of Efficacy

In 2016, results from the LEADER trial of liraglutide in patients with type 2 diabetes helped jumpstart awareness of the potential role of this new...

Older, Sicker Diabetes Patients Have Worse COVID-19 Prognosis

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A large meta-analysis of patients with COVID-19 and diabetes “provides the...

Study Finds Psoriasis Associated With an Increased COVID-19 Risk

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. People with psoriasis have a higher risk of infection with COVID-19...

Promising Data on Once-Weekly Insulin, Phase 3 Study Ongoing

Two new phase 2 studies show encouraging findings with the investigational once-weekly basal insulin analogue icodec (Novo Nordisk) for people with type 2 diabetes who...

Wearable Continuous Ketone Monitoring Appears Feasible

Continuous measurement of ketone levels with a wearable device is feasible, new research suggests. A small sensing device worn on the upper arm, similar to...